Reviving Stocks in Expert’s Opinion: DryShips Inc. (NASDAQ:DRYS), Expedia, Inc. (NASDAQ:EXPE)

Shares of DryShips Inc. (NASDAQ:DRYS) [Trend Analysis] runs in leading trade, it moving up 434.65% to traded at $5.40. The firm has price volatility of 28.70% for a week and 16.32% for a month. Its beta stands at 3.14 times. DryShips Inc. (NASDAQ: DRYS ), a diversified owner of ocean group cargo vessels, reported recently that it has acquired one Very Large Gas Carrier currently under construction at Hyundai Heavy Industries for a purchase price of $83.5 million. The Company financed the closing price of $21.9 million by using part its undrawn liquidity under the $200.0 million New Sifnos Revolver, which now stands at $142.9 million.

Mr. Anthony Kandylidis, President and Chief Financial Officer commented: “We are very pleased to have acquired our first high specification VLGC newbuilding opening a new era of investments since the restructuring of our balance sheet. The closing of our first investment in the gas carrier section, which we believe will be highly accretive to earnings and cash flow, was financed by our New Sifnos Revolver evidencing once more Mr. George Economou’ s commitment to DryShips.”

Narrow down four to firm performance, its weekly performance was 188.77% and monthly performance was 11.34%. The stock price of DRYS is moving up from its 20 days moving average with 85.12% and isolated negatively from 50 days moving average with -34.24%.

Several matter pinch shares of Expedia, Inc. (NASDAQ:EXPE) [Trend Analysis], as shares moving up 0.06% to $119.99 with a share volume of 1.37 Million. The EXPE held a rough session during the week but was ready to get some critical analysis. The stock was assessed by a pool of analysts at WSJ and came out with some serious outcomes not to be avoided before making investment. The EXPE ratings chart showed that 6 gave HOLD ratings for the current month as 4 analysts opting for Overweight option for same period. For stocks’ current month, 22 analysts opted for BUY ratings as compared to 1 opting for SELL in the same period. The stock price target chart showed average price target of 140.97 as compared to current price of 119.99.

Taking look on per share earnings estimates, its next year first quarter current estimate trend for EPS was for $0.36 and on annual basis FY 2016 estimate trends at current was for $4.72 as compared to one month ago of $4.74, and for next year per share earnings estimates have $6.04.

The stock is going forward its 52-week low with 36.95% and moving down from its 52-week high price with -9.96%. To have technical analysis views, liquidity ratio of a company was calculated 0.50 as evaluated with its debt to equity ratio of 0.82. The float short ratio was 8.85%, as compared to sentiment indicator; Short Ratio was 4.81.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *